Apellis Pharmaceuticals I... (APLS)
NASDAQ: APLS
· Real-Time Price · USD
27.77
0.15 (0.54%)
At close: Aug 15, 2025, 3:59 PM
28.85
3.91%
After-hours: Aug 15, 2025, 04:56 PM EDT
Apellis Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 178.49M | 166.8M | 212.53M | 196.83M | 199.69M | 172.32M | 146.38M | 110.4M | 94.97M | 44.85M | 22.66M | 22.06M | 16.32M | 14.38M | 60.29M | 5.65M | 623K | n/a |
Cost of Revenue | 14.07M | 34.36M | 40.86M | 33.56M | 23.55M | 20.65M | 19.91M | 22.41M | 8.38M | 7.81M | 2.92M | 1.38M | 82K | 1.25M | 5.05M | 149K | 50M | 124.59M |
Gross Profit | 164.42M | 132.44M | 171.67M | 163.27M | 176.14M | 151.67M | 126.47M | 87.99M | -9.07M | 37.04M | 19.74M | 20.68M | 16.24M | 13.13M | 55.24M | 5.17M | -49.38M | -124.59M |
Operating Income | -33.29M | -83.33M | -26.16M | -47.28M | -29.44M | -62.09M | -84.52M | -148.3M | -120.44M | -175.08M | -164.05M | -152.94M | -148.62M | -129M | -89.4M | -128M | -194.29M | -124.59M |
Interest Income | 2.61M | 2.66M | 3.4M | 2.89M | 3.18M | 3.3M | 4.55M | 4.99M | 6M | 5.39M | 4.58M | 2.81M | 1.43M | 98K | 37K | 144K | 104K | 134K |
Pretax Income | -41.69M | -91.88M | -36.07M | -56.85M | -37.54M | -66.25M | -87.15M | -140M | -121.84M | -177.5M | -167.46M | -190.82M | -155.49M | -137.73M | -147.58M | -195.57M | -219.19M | -183.66M |
Net Income | -42.15M | -92.22M | -36.35M | -57.45M | -37.66M | -66.42M | -88.58M | -140.24M | -122.04M | -177.78M | -165.99M | -191.27M | -155.98M | -138.94M | -147.93M | -195.57M | -219.19M | -183.66M |
Selling & General & Admin | 130.69M | 129.34M | 121.48M | 121.98M | 127.63M | 129.06M | 141.7M | 145.65M | 111.37M | 102.09M | 84.37M | 78.41M | 63.2M | 51.19M | 41.46M | 45.76M | 48.97M | 40.58M |
Research & Development | 67.02M | 86.42M | 76.35M | 88.57M | 77.95M | 84.7M | 69.28M | 79.42M | 95.66M | 110.03M | 99.42M | 95.21M | 101.66M | 90.94M | 108.18M | 87.73M | 145.94M | 84.01M |
Other Expenses | n/a | n/a | n/a | n/a | 24K | -499K | 219K | -603K | -63K | -277K | -246K | 99K | 149K | -289K | -4K | -117K | -61K | 1.54M |
Operating Expenses | 197.71M | 215.76M | 197.84M | 210.55M | 205.58M | 213.76M | 210.98M | 225.07M | 207.03M | 212.12M | 183.79M | 173.61M | 164.86M | 142.13M | 144.64M | 133.5M | 144.91M | 124.59M |
Interest Expense | 11.15M | 11.05M | 11.53M | 12.53M | 9.36M | 6.97M | 7.4M | 7.31M | 7.34M | 7.53M | 7.74M | 7.9M | 8.45M | 8.54M | 3.02M | 2.28M | 3.77M | 4.17M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 211.78M | 250.13M | 238.69M | 244.11M | 229.13M | 234.41M | 230.9M | 247.48M | 215.41M | 219.93M | 186.72M | 174.99M | 164.95M | 143.38M | 149.69M | 133.65M | 194.91M | 124.59M |
Income Tax Expense | 466K | 341K | 286K | 592K | 114K | 170K | 1.42M | 233K | 194K | 282K | -1.47M | 446K | 486K | 1.21M | 352K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 126.02M | 125.45M | 123.9M | 123.9M | 123.9M | 122.96M | 121.23M | 120.29M | 119.32M | 113.87M | 110.63M | 109.13M | 106.63M | 97.84M | 85.66M | 85.66M | 80.65M | 79.22M |
Shares Outstanding (Diluted) | 126.02M | 125.45M | 123.9M | 123.9M | 123.9M | 122.96M | 121.23M | 120.29M | 119.32M | 113.87M | 110.63M | 109.13M | 106.63M | 98.07M | 85.66M | 85.66M | 80.65M | 79.22M |
EPS (Basic) | -0.33 | -0.74 | -0.29 | -0.46 | -0.3 | -0.54 | -0.73 | -1.17 | -1.02 | -1.56 | -1.5 | -1.75 | -1.46 | -1.42 | -1.73 | -2.28 | -2.72 | -2.32 |
EPS (Diluted) | -0.33 | -0.74 | -0.29 | -0.46 | -0.3 | -0.54 | -0.73 | -1.17 | -1.02 | -1.56 | -1.5 | -1.75 | -1.46 | -1.42 | -1.73 | -2.28 | -2.72 | -2.32 |
EBITDA | -30.09M | -80.39M | -24.09M | -43.86M | -27.73M | -58.84M | -79.26M | -132.29M | -114.09M | -169.57M | -159.3M | -182.56M | -146.7M | -128.83M | -144.19M | -193.01M | -214.98M | -179.09M |
EBIT | -30.53M | -80.83M | -24.53M | -44.32M | -28.18M | -59.29M | -79.75M | -132.69M | -114.5M | -169.97M | -159.72M | -182.92M | -147.04M | -129.19M | -144.72M | -193.29M | -215.42M | -179.48M |
Depreciation & Amortization | 446K | 446K | 447K | 457K | 449K | 444K | 490K | 405K | 410K | 399K | 428K | 357K | 342K | 360K | 376K | 274K | 448K | 394K |